Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DEXILANT SOLUTAB

DEXLANSOPRAZOLE

Standard Dose
30MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DEXILANT SOLUTAB is listed in Drugs@FDA under application 208056 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXLANSOPRAZOLE Form and strength TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL - 30MG Sponsor TAKEDA PHARMS USA Submission history Latest submission status date: 2016-10-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview DEXILANT SOLUTAB is listed in Drugs@FDA under application 208056 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXLANSOPRAZOLE Form and strength TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL - 30MG Sponsor TAKEDA PHARMS USA Submission history Latest submission status date: 2016-10-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
DEXILANT SOLUTAB (DEXLANSOPRAZOLE) | Drug Monograph | MedicHelpline